America’s biopharmaceutical companies are working to discover and develop new medicines for patients. These efforts are paying off with remarkable gains in the fight against disease.
In an era of rapid scientific advancement, America’s biopharmaceutical researchers are working tirelessly to translate new findings into innovative treatments for patients.
When patients get better, the positive effects radiate out beyond families and friends to strengthen the entire U.S. health system.
America’s biopharmaceutical research companies are making important economic contributions in communities across the U.S.
Click to watch the live stream and join the conversation. #PhRMA16
Share Your Story
But there is hope in the form of two phase II clinical trials
underway that could help Ellie and the tens of thousands of other children and
adults fighting mitochondrial disease.
That hope – and innovative medical care – has Ellie back on
her feet, running toward a future that could be very bright, indeed.